Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Neurogen describes D3 receptor-specific ligands

Jan. 12, 1998

Chiroscience synthesizes new MMP/TNF-inhibitory agents

Jan. 12, 1998

Merck discloses novel D4 receptor ligands

Jan. 9, 1998

Ares-Serono's recombinant IFN-beta1a recommended for approval by CPMP for MS

Jan. 9, 1998

Serotone introduced in China

Jan. 9, 1998

CNS-5161 shows efficacy in phase I trial

Jan. 9, 1998

Selective dopamine D3 ligands revealed by Neurogen

Jan. 8, 1998

New NMDA/AMPA antagonists synthesized at Merck & Co.

Jan. 8, 1998

CoCensys and MGH expand license for migraine treatment technology

Jan. 8, 1998

Efficacy of muscle relaxant established in preclinical models

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...